Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Emory University
M.D. Anderson Cancer Center
Nagoya University
University of Chicago
Astellas Pharma Inc
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
pharmaand GmbH
Mayo Clinic
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
Fox Chase Cancer Center
UNICANCER
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Karolinska University Hospital
Eli Lilly and Company
Cardiff University
Cardiff University
Dendreon
SWOG Cancer Research Network
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Southern California
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
National Cancer Institute (NCI)
SWOG Cancer Research Network
National Cancer Institute (NCI)
SWOG Cancer Research Network
SWOG Cancer Research Network
M.D. Anderson Cancer Center
SWOG Cancer Research Network
European Organisation for Research and Treatment of Cancer - EORTC